Three previously undescribed compounds named rauvolphyllas A‐C (1‐3), along with thirteen known compounds, 18β‐hydroxy‐3‐epi‐α‐yohimbine (4), yohimbine (5), α‐yohimbine (6), 17‐epi‐α‐yohimbine (7), (E)‐vallesiachotamine (8), (Z)‐vallesiachotamine (9), 16S‐E‐isositsirikine (10), Nb–methylisoajimaline (11), Nb–methylajimaline (12), ajimaline (13), (+)‐lyoniresinol 3α‐O‐β‐D‐glucopyranoside (14), (+)‐isolarisiresinol 3α‐O‐β‐D‐glucopyranoside (15), and (‐)‐lyoniresinol 3α‐O‐β‐D‐glucopyranoside (16) were isolated from the aerial parts of Rauvolfiatetraphylla L. Their chemical structures were elucidated based on the extensive spectroscopic interpretation of HR‐ESI‐MS, 1D and 2D NMR spectra. The absolute configurations of 2 and 3 were determined by experimental ECD spectra. Compounds 5, 6, 7, and 11‐13 exhibited nitric oxide production inhibition activity in LPS‐activated RAW 264.7 cells with the IC50 values of 79.10, 44.34, 51.28, 33.54, 37.67, and 28.56 μM, respectively, compared to that of the positive control, dexamethasone, which showed IC50 value of 13.66 μM. The other isolates were inactive with IC50 values over 100 μM